Mouse Anti-LMNB2 Recombinant Antibody (CBYJL-1861) (CBMAB-L1844-YJ)
Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
A rare childhood disease characterized by loss of subcutaneous fat from the face and trunk. Fat deposition on the pelvic girdle and lower limbs is normal or excessive. Most frequently, onset between 5 and 15 years of age. Most affected subjects are females and some show no other abnormality, but many develop glomerulonephritis, diabetes mellitus, hyperlipidemia, and complement deficiency. Mental retardation in some cases. APLD is a sporadic disorder of unknown etiology.
Epilepsy, progressive myoclonic 9 (EPM9):
A form of progressive myoclonic epilepsy, a clinically and genetically heterogeneous group of disorders defined by the combination of action and reflex myoclonus, other types of epileptic seizures, and progressive neurodegeneration and neurocognitive impairment. EPM9 is an autosomal recessive form characterized by myoclonus, tonic-clonic seizures, ataxia, and delayed psychomotor development.
Microcephaly 27, primary, autosomal dominant (MCPH27):
A form of microcephaly, a disease defined as a head circumference more than 3 standard deviations below the age, sex and ethnically matched mean. Brain weight is markedly reduced and the cerebral cortex is disproportionately small. MCPH27 is an autosomal dominant form apparent in early childhood and associated with global developmental delay, delayed walking, inability to walk, impaired intellectual development, and poor or absent speech. Brain imaging may show enlarged ventricles or gyral abnormalities in some patients.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Mouse Anti-LMNB2 Recombinant Antibody (CBYCL-385) (CAT#: CBMAB-L0286-YC)
Mouse Anti-LMNB2 Recombinant Antibody (CBYCL-386) (CAT#: CBMAB-L0287-YC)
Mouse Anti-LMNB2 Recombinant Antibody (CBYJL-1863) (CAT#: CBMAB-L1846-YJ)
Mouse Anti-LMNB2 Recombinant Antibody (A914) (CAT#: CBMAB-AP11489LY)
Rabbit Anti-LMNB2 Recombinant Antibody (E1S1Q) (CAT#: CBMAB-CP1341-LY)
Mouse Anti-LMNB2 Recombinant Antibody (CBYCL-387) (CAT#: CBMAB-L0288-YC)
Mouse Anti-LMNB2 Recombinant Antibody (X67) (CAT#: CBMAB-P0471-YC)
Mouse Anti-LMNB2 Recombinant Antibody (CBYJL-1862) (CAT#: CBMAB-L1845-YJ)
Mouse Anti-LMNB2 Recombinant Antibody (X155) (CAT#: CBMAB-L2801-YJ)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us

